Preterm Birth Clinical Trial
Official title:
Cervix Monitor for Risk Assessment of Spontaneous Preterm Delivery
NCT number | NCT03199079 |
Other study ID # | CM01A/B |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 1, 2017 |
Est. completion date | October 11, 2022 |
Verified date | April 2020 |
Source | Advanced Tactile Imaging, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Preterm birth is a leading global cause of neonatal mortality despite of numerous advances and intensive research in perinatal medicine. Almost one million children die each year due to complications of preterm birth and in almost all countries with reliable data, preterm birth rates are increasing. Of the 14 million survivors per year, many face a lifetime of disability, including learning disabilities, visual and hearing impairments. Spontaneous preterm delivery (SPTD) is often multi factorial event, precocious cervical softening, shortening and dilatation are a common denominator. The majority of preterm births happen spontaneously, though some are due to early induction of labor or cesarean birth, typically due to medical maternal of neonatal conditions.
Status | Completed |
Enrollment | 20 |
Est. completion date | October 11, 2022 |
Est. primary completion date | April 27, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 21 Years to 44 Years |
Eligibility | Inclusion Criteria: 1. Adult women age 21-44 years 2. Non-pregnant women, or 3. Pregnant women Exclusion Criteria: 1. Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder 2. Ongoing or prior radiation therapy for abdominal or pelvic cancer 3. Recent (less than four months) pelvic surgery 4. Surgically absent uterus, rectum or bladder 5. Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician 6. Severe abdominal or pelvic adhesions preventing access to pertinent anatomy 7. Known or suspected bleeding disorder 8. HIV or hepatitis B positive serology 9. Warty lesions on the vulva 10. Extensive varicose veins on the vulva 11. Active skin infection or ulceration within the vagina/vulva (Herpes infection) 12. Presence of a vaginal septum 13. Severe hemorrhoids |
Country | Name | City | State |
---|---|---|---|
United States | Rutgers Robert Wood Johnson Medical School | New Brunswick | New Jersey |
United States | Princeton Urogynecology | Princeton | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Advanced Tactile Imaging, Inc. | Princeton Urogynecology, Rutgers, The State University of New Jersey |
United States,
Egorov V, Rosen T, van Raalte H, Kurtenoks V. Cervical Characterization with Tactile-Ultrasound Probe. Open J Obstet Gynecol. 2020 Jan;10(1):85-99. doi: 10.4236/ojog.2020.101008. Epub 2020 Jan 8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cervix Elasticity | Young's modulus of the cervix at 4 locations. Units of measurement is kPa. | During examination procedure | |
Secondary | Cervix Length | Cervix length in mm | During examination procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04021654 -
What is the Future of Vulnerable New-borns
|